Astrazeneca

Share
Save

Vision / R&D

Leadership

Finance / Economy

Talent / People / Culture

Innovation / Livability

Smart policies / Tax incentives

Sustainability

Social impact

Number of employees	70.6K

Products	Nexium® (esomeprazole), Onglyza® (saxagliptin), Oxis® Turbohaler (formoterol), Lynparza® (olaparib), Plendil® (felodipine), Pulmicort® (budesonide), Qtern® (dapagliflozin/saxagliptin), Seroquel XL® (quetiapine).

Operating Status	Active

Headquarters	Cambridge, Cambridgeshire, United Kingdom

Type	Health Technology

Established	1999

Net Income	US$1.227 billion (2019)

Revenue	US$24.384 billion (2019)

Industry/Categories	Health Technology

Traded as	AZN

Own or work here? Claim Now! Claim Now!

Claiming your business

Full Name*

Phone*

Verfication Details

Secure claim process

Why should I claim ?

You can easily claim your business to unlock and access your dashboard where where you can get total of your business listings. You can start generating more leads by starting ads campaign or offer coupons or deals.

Earn claimed badge to indicate verified., add photos, video etc.
Edit business listing, add photos, video etc.
Promote your listing with ads to drive sales.
Start receiving messages from lead.
Create Deals/Coupons, add photos, video etc.

Claim This Listing

Contents

1 Summary
2 History
3 Vision
4 Mission
5 References

Summary

AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation.

History

AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK – two companies with similar science-based cultures and a shared vision of the pharmaceutical industry.

The merger aimed to improve the combined companies’ ability to deliver long term growth and enduring shareholder value through: